Financhill
Back

Altamira Therapeutics Ltd. Stock Predictions

Altamira Therapeutics Ltd. Stock Forecast

  • Is Altamira Therapeutics Ltd. Stock Undervalued?
    The current Altamira Therapeutics Ltd. [CYTOF] share price is $0.07. The Score for CYTOF is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • CYTOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Altamira Therapeutics Ltd. Stock Go Up Next Year?

Data Unavailable

Altamira Therapeutics Ltd. Stock Rating

Data Unavailable

Altamira Therapeutics Ltd. Stock Price History

Is CYTOF stock going to rise?

  • The current trend is relatively stagnant and CYTOF is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
OTCM
Country:
Bermuda
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
altamiratherapeutics.com

52-Week Data

52-Week High:
0.58
52-Week Low:
0.05

Prediction Charts

Market Cap:
303.3K
Price in USD:
0.07
Volume:
21
Beta:
0.92

Technical Analysis

SMA50:
0.08
SMA100:
0.08
SMA200:
0.08
52-Wk Change:
-86.68%

Stock Predictions

  • Is Altamira Therapeutics Ltd. stock public?
    Yes, Altamira Therapeutics Ltd. is a publicly traded company.
  • What is the Altamira Therapeutics Ltd. stock quote today?
    The Altamira Therapeutics Ltd. stock price is 0.07 USD today.
  • How to buy Altamira Therapeutics Ltd. stock online?
    You can buy Altamira Therapeutics Ltd. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-17 0.09 0.09 0.09 0.09
Nov-18 0.09 0.09 0.09 0.09
Nov-19 0.09 0.09 0.09 0.09
Nov-20 0.09 0.07 0.10 0.07
Nov-21 0.10 0.08 0.10 0.08
Nov-24 0.07 0.07 0.07 0.07
Nov-25 0.07 0.07 0.08 0.07
Nov-26 0.07 0.07 0.07 0.07
Nov-28 0.07 0.07 0.07 0.07
Dec-1 0.07 0.07 0.07 0.07
Dec-2 0.07 0.06 0.07 0.06
Dec-3 0.07 0.08 0.08 0.07
Dec-4 0.07 0.07 0.07 0.07
Dec-5 0.07 0.07 0.07 0.07

Altamira Therapeutics Ltd. Earnings

Data Unavailable

Altamira Therapeutics Ltd. Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.48 per share, and a decrease next year of $0.00 per share.

* Altamira Therapeutics Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.